Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $10.13 and traded as low as $7.87. Bavarian Nordic A/S shares last traded at $8.05, with a volume of 7,983 shares changing hands.
Bavarian Nordic A/S Stock Performance
The firm has a market cap of $1.89 billion, a P/E ratio of 11.77 and a beta of 1.68. The stock's 50-day moving average is $8.92 and its 200 day moving average is $10.10.
About Bavarian Nordic A/S
(
Get Free Report)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Further Reading
Before you consider Bavarian Nordic A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic A/S wasn't on the list.
While Bavarian Nordic A/S currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
